241 related articles for article (PubMed ID: 29924296)
41. Lymphoma in Adolescents and Young Adults: Current Perspectives.
Hochberg J; Cairo MS
Cancer J; 2018; 24(6):285-300. PubMed ID: 30480573
[TBL] [Abstract][Full Text] [Related]
42. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
Lowrance WT; Breau RH; Chou R; Chapin BF; Crispino T; Dreicer R; Jarrard DF; Kibel AS; Morgan TM; Morgans AK; Oh WK; Resnick MJ; Zietman AL; Cookson MS
J Urol; 2021 Jan; 205(1):22-29. PubMed ID: 32960678
[TBL] [Abstract][Full Text] [Related]
43. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
44. ESMO expert consensus statements on the screening and management of financial toxicity in patients with cancer.
Carrera PM; Curigliano G; Santini D; Sharp L; Chan RJ; Pisu M; Perrone F; Karjalainen S; Numico G; Cherny N; Winkler E; Amador ML; Fitch M; Lawler M; Meunier F; Khera N; Pentheroudakis G; Trapani D; Ripamonti CI
ESMO Open; 2024 May; 9(5):102992. PubMed ID: 38626634
[TBL] [Abstract][Full Text] [Related]
45. Appendix 1: Cancer of the Prostate: eUpdate published online 28 September 2017 (http://www.esmo.org/Guidelines/Genitourinary-Cancers/Cancer-of-the-Prostate).
ESMO Guidelines Committee
Ann Oncol; 2018 Oct; 29(Suppl 4):iv256. PubMed ID: 30285212
[No Abstract] [Full Text] [Related]
46. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
[TBL] [Abstract][Full Text] [Related]
47. The era of meta-analyses-based recommendations: how were the Japanese Breast Cancer Society Clinical Practice Guidelines for Systemic Treatment of Breast Cancer established?
Takano T
Breast Cancer; 2020 May; 27(3):332-333. PubMed ID: 32342405
[No Abstract] [Full Text] [Related]
48. ESMO clinical recommendations: using the easier and faster approach to oncology guidelines.
Pavlidis N; Hansen H; Stahel R
Ann Oncol; 2009 May; 20 Suppl 4():7-9. PubMed ID: 19454468
[No Abstract] [Full Text] [Related]
49. Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper.
Zinzani PL; Corradini P; Martelli M; Minotti G; Oliva S; Spina M; Barosi G; Tura S
Eur J Haematol; 2016 Dec; 97(6):554-561. PubMed ID: 27124765
[TBL] [Abstract][Full Text] [Related]
50. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
51. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
52. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
van de Velde CJ; Aristei C; Boelens PG; Beets-Tan RG; Blomqvist L; Borras JM; van den Broek CB; Brown G; Coebergh JW; Cutsem EV; Espin E; Gore-Booth J; Glimelius B; Haustermans K; Henning G; Iversen LH; Han van Krieken J; Marijnen CA; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten HJ; Schmoll HJ; Smith J; Tanis PJ; Taylor C; Wibe A; Gambacorta MA; Meldolesi E; Wiggers T; Cervantes A; Valentini V;
Eur J Cancer; 2013 Sep; 49(13):2784-90. PubMed ID: 23769991
[TBL] [Abstract][Full Text] [Related]
53. Levels of evidence and grades of recommendation supporting European society for medical oncology clinical practice guidelines.
Skelin M; Perkov-Stipičin B; Vušković S; Šandrk Plehaček M; Bašić A; Šarčević D; Ilić M; Krečak I
Oncol Res; 2024; 32(5):807-815. PubMed ID: 38686053
[TBL] [Abstract][Full Text] [Related]
54. Policy statement on multidisciplinary cancer care.
; Borras JM; Albreht T; Audisio R; Briers E; Casali P; Esperou H; Grube B; Hamoir M; Henning G; Kelly J; Knox S; Nabal M; Pierotti M; Lombardo C; van Harten W; Poston G; Prades J; Sant M; Travado L; Valentini V; van de Velde C; van den Bogaert S; van den Bulcke M; van Hoof E; van den Neucker I; Wilson R
Eur J Cancer; 2014 Feb; 50(3):475-80. PubMed ID: 24321260
[TBL] [Abstract][Full Text] [Related]
55. [EAU guidelines on testicular cancer: 2011 update. European Association of Urology].
Albers P; Albrecht W; Algaba F; Bokemeyer C; Cohn-Cedermark G; Fizazi K; Horwich A; Laguna MP;
Actas Urol Esp; 2012 Mar; 36(3):127-45. PubMed ID: 22188753
[TBL] [Abstract][Full Text] [Related]
56. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Casali PG; Abecassis N; Aro HT; Bauer S; Biagini R; Bielack S; Bonvalot S; Boukovinas I; Bovee JVMG; Brodowicz T; Broto JM; Buonadonna A; De Álava E; Dei Tos AP; Del Muro XG; Dileo P; Eriksson M; Fedenko A; Ferraresi V; Ferrari A; Ferrari S; Frezza AM; Gasperoni S; Gelderblom H; Gil T; Grignani G; Gronchi A; Haas RL; Hassan B; Hohenberger P; Issels R; Joensuu H; Jones RL; Judson I; Jutte P; Kaal S; Kasper B; Kopeckova K; Krákorová DA; Le Cesne A; Lugowska I; Merimsky O; Montemurro M; Pantaleo MA; Piana R; Picci P; Piperno-Neumann S; Pousa AL; Reichardt P; Robinson MH; Rutkowski P; Safwat AA; Schöffski P; Sleijfer S; Stacchiotti S; Sundby Hall K; Unk M; Van Coevorden F; van der Graaf WTA; Whelan J; Wardelmann E; Zaikova O; Blay JY;
Ann Oncol; 2018 Oct; 29(Suppl 4):iv68-iv78. PubMed ID: 29846513
[No Abstract] [Full Text] [Related]
57. Highlights in lymphoma: overview of the 11th International Conference on Malignant Lymphoma.
Chiappella A; Vitolo U
Expert Rev Hematol; 2011 Oct; 4(5):491-4. PubMed ID: 21939417
[TBL] [Abstract][Full Text] [Related]
58. Management of B-cell non-Hodgkin lymphoma in Asia: resource-stratified guidelines.
Tan D; Tan SY; Lim ST; Kim SJ; Kim WS; Advani R; Kwong YL
Lancet Oncol; 2013 Nov; 14(12):e548-61. PubMed ID: 24176573
[TBL] [Abstract][Full Text] [Related]
59. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB; Louis TA; Markman M; Mayer R; Roter D
J Natl Cancer Inst; 2001 Jul; 93(13):979-89. PubMed ID: 11438563
[TBL] [Abstract][Full Text] [Related]
60. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
